Robert Flavell, MD, PhD

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Robert Flavell, MD, PhD sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials 2 currently recruiting early-phase tilt upper quartile by trial count

Robert Flavell, MD, PhD: 5 sponsored US clinical trials, 2 recruiting.

Robert Flavell, MD, PhD sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 2 trials.

Upper-quartile sponsor footprint

Robert Flavell, MD, PhD sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

5 total, page 1 of 1

RECRUITING Phase 1

PET [89Zr]DFO-starPEG in Solid Tumors

NCT06894745
RECRUITING Phase 1

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

NCT05892393
ACTIVE NOT RECRUITING Early Phase 1

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

NCT05851365
ACTIVE NOT RECRUITING Phase 1

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

NCT05245006
NOT YET RECRUITING Phase 1

Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

NCT07664397

Phase Distribution

PhaseTrial count
Phase 1 5

Therapeutic Areas

Prostate Cancer 2
Soft Tissue Lesion 1
Solid Carcinoma 1
Plasma Cell Myeloma 1
Multiple Myeloma 1
Localized Prostate Carcinoma 1
Metastatic Castration-Resistant Prostate Cancer 1
Solid Tumor 1

What is open in the Robert Flavell, MD, PhD pipeline

2 recruiting of 5 indexed (40% open).

Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).

Top condition: Prostate Cancer (2 trials), 7 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Robert Flavell, MD, PhD: open-pipeline peers nationwide

Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.

Robert Flavell, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4681012 0%10%20%30%40%50% Total trials Recruiting share Robert Flavell, MD, PhD4YouandMeAbbott Rapid DxAccess Business GroupAcera SurgicalAd scientiamAlto NeuroscienceBonafide HealthBrooks Rehabilitation
Robert Flavell, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Robert Flavell, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 trials (± recruiting share)

Sponsors near 40% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Robert Flavell, MD, PhD page

5 registered trials is a research-attention snapshot, not an endorsement of Robert Flavell, MD, PhD or any single study.

  • 2 of Robert Flavell, MD, PhD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Prostate Cancer is the condition Robert Flavell, MD, PhD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Robert Flavell, MD, PhD pipeline card: 5 registered trials from official public datasets.Report a data error.